RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.77
+0.22 (2.57%)
Aug 28, 2025, 12:30 PM - Market open

RxSight Statistics

Total Valuation

RxSight has a market cap or net worth of $358.83 million. The enterprise value is $140.27 million.

Market Cap358.83M
Enterprise Value 140.27M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

RxSight has 40.92 million shares outstanding. The number of shares has increased by 9.84% in one year.

Current Share Class 40.92M
Shares Outstanding 40.92M
Shares Change (YoY) +9.84%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 5.27%
Owned by Institutions (%) 81.51%
Float 32.44M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.35
Forward PS 2.89
PB Ratio 1.26
P/TBV Ratio 1.28
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.95
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.93, with a Debt / Equity ratio of 0.04.

Current Ratio 13.93
Quick Ratio 12.54
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2,025.33

Financial Efficiency

Return on equity (ROE) is -11.66% and return on invested capital (ROIC) is -9.22%.

Return on Equity (ROE) -11.66%
Return on Assets (ROA) -8.65%
Return on Invested Capital (ROIC) -9.22%
Return on Capital Employed (ROCE) -14.74%
Revenue Per Employee $295,299
Profits Per Employee -$64,763
Employee Count498
Asset Turnover 0.48
Inventory Turnover 1.78

Taxes

In the past 12 months, RxSight has paid $75,000 in taxes.

Income Tax 75,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.69% in the last 52 weeks. The beta is 1.15, so RxSight's price volatility has been higher than the market average.

Beta (5Y) 1.15
52-Week Price Change -84.69%
50-Day Moving Average 9.41
200-Day Moving Average 23.00
Relative Strength Index (RSI) 49.54
Average Volume (20 Days) 1,208,421

Short Selling Information

The latest short interest is 5.77 million, so 14.11% of the outstanding shares have been sold short.

Short Interest 5.77M
Short Previous Month 6.23M
Short % of Shares Out 14.11%
Short % of Float 17.80%
Short Ratio (days to cover) 4.86

Income Statement

In the last 12 months, RxSight had revenue of $147.06 million and -$32.25 million in losses. Loss per share was -$0.80.

Revenue147.06M
Gross Profit 107.53M
Operating Income -42.53M
Pretax Income -36.75M
Net Income -32.25M
EBITDA -39.32M
EBIT -42.53M
Loss Per Share -$0.80
Full Income Statement

Balance Sheet

The company has $227.49 million in cash and $11.72 million in debt, giving a net cash position of $215.78 million or $5.27 per share.

Cash & Cash Equivalents 227.49M
Total Debt 11.72M
Net Cash 215.78M
Net Cash Per Share $5.27
Equity (Book Value) 278.01M
Book Value Per Share 6.80
Working Capital 263.49M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.82 million and capital expenditures -$4.06 million, giving a free cash flow of -$20.88 million.

Operating Cash Flow -16.82M
Capital Expenditures -4.06M
Free Cash Flow -20.88M
FCF Per Share -$0.51
Full Cash Flow Statement

Margins

Gross margin is 73.12%, with operating and profit margins of -28.92% and -21.93%.

Gross Margin 73.12%
Operating Margin -28.92%
Pretax Margin -21.88%
Profit Margin -21.93%
EBITDA Margin -26.74%
EBIT Margin -28.92%
FCF Margin n/a

Dividends & Yields

RxSight does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.84%
Shareholder Yield -9.84%
Earnings Yield -9.06%
FCF Yield -5.86%
Dividend Details

Analyst Forecast

The average price target for RxSight is $11.80, which is 34.55% higher than the current price. The consensus rating is "Hold".

Price Target $11.80
Price Target Difference 34.55%
Analyst Consensus Hold
Analyst Count 11
Revenue Growth Forecast (5Y) 3.02%
EPS Growth Forecast (5Y) -7.82%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RxSight has an Altman Z-Score of 25.59 and a Piotroski F-Score of 3.

Altman Z-Score 25.59
Piotroski F-Score 3